Lund Systemic Sclerosis Research Group
51 – 60 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
(
- Contribution to journal › Letter
-
Mark
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis : Results from the SPARTAKUS cohort
(
- Contribution to journal › Article
-
Mark
Patientens perspektiv på att leva med PAH eller CTEPH i Sverige : Enkätstudie visar på betydelsen av adekvat och upprepad information
(
- Contribution to journal › Article
-
Mark
CMR feature tracking in cardiac asymptomatic systemic sclerosis : Clinical implications
(
- Contribution to journal › Article
-
Mark
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
(
- Contribution to journal › Article
- 2018
-
Mark
Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis : A magnetic resonance study
(
- Contribution to journal › Article
-
Mark
Common measure of quality of life for people with systemic sclerosis across seven European countries : A cross-sectional study
(
- Contribution to journal › Article
-
Mark
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article